首页>
外国专利>
TREATING SYD985 PATIENTS WITH T-DM1 REFRACTORY CANCER
TREATING SYD985 PATIENTS WITH T-DM1 REFRACTORY CANCER
展开▼
机译:用T-DM1耐癌治疗SYD985患者
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the duocarmycin-containing antibody-drug conjugate (ADC) trastuzumab vc-seco-DUBA (SYD985) for use in the treatment of trastuzumab emtansine (T-DM1) refractory HER2 IHC 3+ or HER2 IHC 2+/FISH positive cancer patients, particularly T-DM1 refractory breast cancer patients.
展开▼